your trusted partner for heor...neha sharan systematic reviewer education: m. pharm pharmacology,...
TRANSCRIPT
YOURTRUSTEDPARTNERFOR HEOR
YOURTRUSTEDPARTNERFOR HEOR
Contact:[email protected]: +91 88005 94510Singapore: +65 6653 4351
1
INTRODUCTION
We are a boutique data analytics consultancy specialising in domain of Health Economics and Outcomes Research (HEOR), pricing, and market access
Our company was formally incorporated on 31 August 2017 with a vision to provide high-quality data analytic services. Over a span of three years, we have cemented our presence as a high-quality service provider serving clients across Australia, Singapore, India, UAE, UK and USA
We provide services to pharmaceutical and medical devices companies as well as support midsize and large consultancies globally
New York
London
Dubai
Mumbai
Sydney
Dhekiajuli
Our Clients
Our Offices
Texas
Maryland
Singapore
San Diego
2
Gurgaon
SERVICES
Model Adaptations
• We conduct model adaptations to suit local country requirements based on their local epidemiological, clinical and treatment settings
• Our team works in close collaboration with the country and global offices to ensure that the adapted model is suitable for decision making in the country of its implementation
Technical Reviews
• We provide independent review of the models developed externally which helps to minimise the risks of technical/formulae errors or methodical errors
• We conduct a detailed thorough sheet by sheet check of the models and use our in-house developed checklist to stress test model on various parameters
HTA Submission
• As per requirement of the health technology assessment (HTA) submission and HTA agency, we select the relevant form of economic evaluation:
❖ Cost utility analysis
❖ Cost effectiveness analysis
❖ Cost minimization analysis
❖ Cost benefit analysis
Economic Model
• We have expertise in developing all kinds of model commonly used in HEOR such as:
❖ Decision tree
❖ Markov model
❖ Partitioned survival analysis or Area under the curve (AUC)
❖ Patient level simulation or discrete event simulation (DES)
3
SERVICES
DataExtraction
• We specialize in high-quality data extraction services for qualitative and quantitative reviews (English language only) with independent quality checks
• We can assist with data extraction from:
❖ Published studies
❖ HTA websites
❖ Grey literature
Miscellaneous Services
• We provide support on a host of miscellaneous services that are an integral part of the HEOR project such as:
❖ Abstracts
❖ Posters
❖ Manuscripts
❖ Scientific slide decks
❖ Value briefs
❖ Ad board
❖ KOL interview
❖ Dashboard
❖ Automation
LiteratureReviews
• We conduct systematic literature review (SLR) as well as targeted literature review (TLR) to identify relevant evidence for the decision problem
• Our literature review process follows the best practice guidelines and provides valuable insights and findings around the research question
Budget Impact Model & Value tools
• We develop user friendly Budget impact models (BIM) to assess the impact on the budget when introducing a new technology/drug
• We do a detailed cost analysis which equips the decision maker with robust information for better planning and allocation of resources
4
5
EpilepsyMultiple SclerosisCognitive BehaviourDepression
CataractMyopia
PresbyopiaChoroidal Neovascularization
Sleep ApnoeaMandibular Fractures
Myocardial InfarctionHeart Failure
Breast CancerBreast Implantation
COPDAsthma
Spinal Cord InjurySpinal Muscular Atrophy
Progeria#Psoriasis*Melanoma*
Polyarticular Juvenile Idiopathic Arthritis*Psoriatic Arthritis*Rheumatoid Arthritis*
Pancreatic Cancer
Knee ImplantOsteochondral Defects
Prostate Cancer
THERAPEUTICAREAS
*affects multiple organ systems#Genetic disorders
Hemant Rathi
Managing Director
Additional position: Adjunct Faculty at Manipal Academy of Higher Education
Education: M.Sc (int) Economics, IIT Kanpur;
Key skills: Patient level simulation, HTA submissions, Economic modelling, Dashboard and model adaptations
Key therapeutic areas: Cardiovascular, Pathological Myopia, Multiple Sclerosis, Oncology, Rheumatoid Arthritis and TRD
Neha Sharan
Systematic Reviewer
Education: M. Pharm Pharmacology, Panjab University
Key skills: Systematic and targeted literature reviews, Dossiers, Manuscripts, Posters and Report writing
Key therapeutic areas: Neurology, Oncology, Psychiatry, Rheumatoid Arthritis and Rare Diseases.
Amit Gupta
Health Economist
Education: M.Sc Statistics, Delhi University
Key skills: Cost effectiveness (CE) and budget impact models (BIMs), Model adaptations, Literature reviews andreport writing
Key therapeutic areas: Oncology, Clostridium Difficile Infection (CDI),Mental health, Anti Microbial Resistanceand Sjogren's Syndrome
Tanu Khurana
Systematic Reviewer
Education: M. Pharm Pharmacy Practice, NIPER, Hajipur
Key skills: Systematic and targeted literature reviews, Access evidence dossiers, Burden of illness reports, Manuscripts, Posters, Report writing and Strategic evidence development
Key therapeutic areas: Oncology, Endocrinology, Rare Diseases, Rheumatoid Arthritis and Psychiatry
MEET OURTEAM
6
Shantanu Jawla
Systematic Reviewer
Education: M.Pharm Pharmacology, DIPSAR, University of Delhi
Key Skills: Systematic and targeted literature reviews, Global value dossiers, Manuscripts and Scientific presentations (posters, abstracts & slide-decks)
Key Therapeutic Areas: Immunology & Dermatology, Respiratory, Neuroscience, Oncology and Medical Devices
Dr. Ritu Gupta
Systematic Reviewer
Education: MPH, Indian Institute of Public Health
Key Skills: Systematic review, Manuscripts, Report writing, Statistical analysis
Key Therapeutic Areas: Acute Myeloid Leukaemia, Medical Devices
Dr. Bhavna Sharma
Systematic Reviewer
Education: M.Sc. Clinical Research, Indian Institute of Public Health- Delhi
Key Skills: Systematic review and Meta-analysis, Statistical analysis, Pharmaceutical policy evaluation, Scientific writing
Key Therapeutic Areas: Oncology,Mental Health
Nitya KalantriHuman Resources & Operation Manager
Education: MBA, NMIMS (GASCE)
Key Skills: Recruitment, Operations, Administration and Project Management
MEET OURTEAM
7
A selected list of publications from our team members
We can assist you with developing high quality
Manuscripts, Abstracts, Posters and
Oral Presentations
PUBLICATIONS
For full list of publications, please click here
8
Hsiao, C.C.W., Jawla, S., Shammas, H.J. (2020). Efficiency and Economic Analysis of Optical Biometers: Experience from a Private Eye Medical Center in the United States of America. Value in Health, 23 (1), S195-S196.
Hsiao, C.C.W., Jawla, S., Dhariwal, M. (2020). LenSx Femtosecond Laser Assisted and Manual Cataract Surgery: A Review of Comparative Effectiveness, Safety and Efficiency Outcomes. Value in Health, 23 (1), S196-S197.
Khurana T., Kumar S., Mondal S. (2020). Value Assessment Frameworks: Have they reached their destination? Value in Health, 23, S310.
Wang, X., Lahoz, R., Jawla, S., Przybysz, R., Kahler, K.H., Burdukova, L., Venkata, S.K., Nassim, M., Jalapu, A., Justo, N. (2019). Identification and mapping of worldwide sources of generic real-world data. Pharmacoepidemiol Drug Saf, 28 (7), 899-905.
Sharan, N., Rathi, H. (2019). Efficacy and Safety of Lonafarnib For the Treatment of Progeria- A Qualitative Systematic Review of Literature. Value in Health, 22 (SUPPL2), S335–S336.
Lynch, K., Aristides, M., Rathi, H., Papadopoulos, G., & McGuire, A. (2018). Cost Analysis of an Intranasal Naloxone Take-Home Program: An Australian Case Study. In DRUG AND ALCOHOL REVIEW, 37(S3), pp. S48-S48.
Khurana, T., Gupta, A., Rathi, H. A Systematic Review of Cost Utility Studies Conducted from an Indian Perspective. Accepted for publication in Value in Health Regional Issues (Online, September 2020).
Khurana, T., Gupta, A., Rathi, H. An Analysis of Utility Values used in Cost Utility Studies Conducted from an Indian Perspective. Accepted for publication in Value in Health Regional Issues (Online, September 2020).
9
Callan, A., Nallagangula, T.K., Jawla, S., Risson V. (2018). Spinal Muscular Atrophy: A Review of Epidemiology, Burden and Unmet needs. Value in Health, 21 (3), S440.
Tarhini, A., Singh, K.G., You, M., Gupta, A., Kim, L.T., Rao, S. (2018). Use of adjuvant interferon alfa-2b or ipilimumab 10 mg/kg for high-risk patients with melanoma and associated adverse events and duration of therapy. Cancer Research, 78 (13), A3641.
Thom, H., Jugl, S.M., Nikoglou, E., Jawla, S. (2017). Matching Adjusted Indirect Comparisons to Assess Comparative Effectiveness - A Systematic Review of Application in Scientific Literature and Health Technology Appraisals. Value in Health, 20 (5), A339.
Sharan, N., Srivastava, K., Akehurst, R., Erder, H., Strzelczyk, A., Bonthapally, V. (2017). Current Treatment Practices and Their Efficacy and Safety in Refractory Or Super-Refractory Status Epilepticus: A Systematic Review. Value in Health, 20 (5), A189.
Rathi, H., Pennington, B.,Amadi, A., Lister, S., Nanuwa, K. (2015) The Efficacy and Safety of Abatacept, Adalimumab, Etanercept And Tocilizumab are Comparable In Polyarticular Juvenile Idiopathic Arthritis. Value in Health, 18 (7), A636.
Jain, M., Sonathi, V., Rathi, H., Bakuli, A., Thomas, S.K., & Mollon, P. (2014) A DE-NOVO Model to Predict Outcomes of a New Hypothetical Intervention to Reduce CV Risk in Post Mi Patients. Value in Health, 17 (7), A558.
Leteneux, C., Claxton, L., Malcolm, W. A., Taylor, M., & Rathi, H. (2013) Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom. Value in Health, 16 (7), A505.
Bergvall, N., Rathi, H., Nixon, R. M., Thom, H. H. Z., Alsop, J., Dunsire, L. (2013) Modeling the Impact of Disease Modifying Treatment on Time to Disability Health States in Multiple Sclerosis: An Evaluation of Oral Therapies Through Indirect Comparisons of 6-Month Confirmed Disability Progression. Value in Health, 16 (7), A619.
10
EVENTSPARTICIPATIONS &
CELEBRATIONS
11
ISPOR 2018HEOR
WORKSHOPISPOR 2019
HTA at NTU,Singapore
TEAM SYKWARD
CONTACT US
Skyward Analytics Pvt. Ltd.
Level 18, DLF Cyber City
Building No.5, Tower A
Gurgaon – 122002,
India
+91 8800 594 510
www.skywardanalytics.com
Skyward Analytics Pte. Ltd.
8 Marina Boulevard
#11-00 marina Bay Financial
Centre Tower 1
Singapore 018981
+65 6653 4351
12